Engineering Gut Microbiome to Target Breast Cancer
Tab Title Description
Describes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
- Jacksonville, Florida: 17-002215
NCT ID: NCT03358511
Sponsor Protocol Number: 17-002215
About this study
The purpose of this study is to find out if using probiotics will help the body's immune system react to breast cancer. New studies showed that diverse species of bacteria inside the bowel might help improve immune system, particularly the ability of immune system to recognize cancer. This study will investigate how probiotics will affect the subjects' immune system on breast cancer.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
- Females ≥ 18 years of age
- Histologically confirmed adenocarcinoma of the breast ≥1.0 cm operable stage I-III
- Must have adequate organ function,
- Not receive systemic neoadjuvant therapy
- Be willing to provide tissue, blood, and stool samples for research study.
- Must not have taken any probiotics in the past 60 days prior to enrollment.
- Patients with autoimmune disease, immune deficiency such as HIV, irritable bowel, known diverticulosis, and other serious GI conditions at treating physician's discretion will be excluded.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
|Mayo Clinic Location
Mayo Clinic principal investigator
Saranya Chumsri, M.D.
Closed for enrollment
Publications are currently not available